Literature DB >> 10826074

Relationship between scholastic and health behaviors and reading level in adolescent females.

S C Matson1, K A Haglund.   

Abstract

This was a study of 102 adolescent females, 12-20 years of age, presenting to a central city clinic for medical care. Participants completed an oral questionnaire that included demographics, and questions regarding scholastic history, sexual behavior, and substance use. Each subject completed the Accuracy Level Test (ALT), a reading test. The subject's reading test grade level was subtracted from her appropriate grade in school to give a reading delay level (RDL). The mean reading grade level for all subjects was 6.7 +/- 2.6 and the average reading delay was 4.5 +/- 2.5 grades. Poor school attenders had greater reading delays (5.8 +/- 3.4 grades behind vs. 4.3 +/- 2.2 for good attenders p < 0.04), and those who repeated grades were also significantly delayed (5.5 +/- 2.4 grades behind vs. 3.7 +/- 2.3, p < 0.0007). Previously pregnant students had a greater delay in reading level than their nonpregnant peers (5.2 +/- 2.3 vs. 3.9 +/- 2.5 respectively p < 0.01). Delayed reading levels appear to correlate with some risk behaviors. The ALT may serve as a tool to identify high-risk patients who need more intensive clinical intervention.

Entities:  

Mesh:

Year:  2000        PMID: 10826074     DOI: 10.1177/000992280003900503

Source DB:  PubMed          Journal:  Clin Pediatr (Phila)        ISSN: 0009-9228            Impact factor:   1.168


  2 in total

1.  Examining the measurement precision and invariance of the revised get ready to read!

Authors:  Amber L Farrington; Christopher J Lonigan
Journal:  J Learn Disabil       Date:  2013-07-12

2.  When things are not as they appear: assessing the adequacy of cluster randomization when outcome events are rare at baseline.

Authors:  Veronica Dinaj-Koci; Nanika Brathwaite; Lynette Deveaux; Sonya Lunn; Lesley Cottrell; Carole Harris; Bonita Stanton; Xiaoming Li; Sharon Marshall; Perry Gomez; Xinguang Chen
Journal:  AIDS Res Treat       Date:  2012-05-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.